Andrew Campbell

Andrew Garrett Campbell is an American biologist who is a professor of Medical Science and Dean of the Graduate School at Brown University. In 2020 he was named by Cell Press as one of the most 100 "inspiring Black scientists in America". Early life and education Campbell studied biology at York College, City University of New York, minoring in French, and graduated in 1981. He moved to the West Coast of the United States for his graduate studies in the laboratory of John H. Fessler, where he studied Drosophila melanogaster at the University of California, Los Angeles. As a graduate student in 1986 Campbell partnered with fellow UCLA graduate student Theodore (Ted) B. Thederahn and UCLA graduate Robert B Laukka to serve as founding directors and principals of the Southern California-based research and radiation safety products manufacturing company, Bremshield Corporation whose products supported the U.S. academic biomedical research community and newly emerging biotech industry. Campbell served as a postdoctoral fellow at both UCLA and the University of California, San Francisco. As a postdoctoral Fellow in the laboratory of Dan S. Ray at UCLA, he began his studies of the endonuclease enzyme RNase H. As a President's Postdoctoral Fellow at UCSF Campbell studied Hepatitis B Virus with William J. Rutter, founder of the Chiron Corporation which would go on to develop the Hepatitis B vaccine as the 1st genetically engineered vaccine to receive FDA approval for human use. Research and career In 1994 Campbell joined the faculty at Brown University as assistant professor of Medical Science. His research considers infectious microbial diseases in neglected populations and regions. In particular, Campbell continued his studies of the endonuclease enzymes Ribonuclease H (RNases H), with which he hopes to better understand nucleic acid metabolic function. He is also interested in the lifecycle of Trypanosoma brucei, a parasite carried by tsetse flies in sub-Saharan Africa. Campbell is also interested in the role of viral RNase-H as therapeutic targets, and has investigated how mutations in RNase-H can give rise to drug resistance. Alongside his research, Campbell develops programs to improve the representation of historically underrepresented minority students in science and technology programs. He was promoted to Dean of the Graduate School in 2016. He is the fifteenth person to hold such a position.